← SynDRA
RITANSERIN
SynDRA canonical compound SYN0000576 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | HTR2C |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
- HTR2A
- HTR2B
- HTR2C
- ADRA1A
- ADRA1B
- ADRA1D
- HTR1A
- HTR1B
- HTR1D
- HTR5A
- HTR6
- HTR7
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR1A ANTAGONIST
- HTR1B ANTAGONIST
- HTR1D ANTAGONIST
- HTR2A ANTAGONIST
- HTR2B ANTAGONIST
- HTR2C ANTAGONIST
- HTR5A ANTAGONIST
- HTR6 ANTAGONIST
- HTR7 ANTAGONIST
- ADRA1A ANTAGONIST
- ADRA1B ANTAGONIST
Drug classes
- Anti-Anxiety Agents
- Antidepressive Agents, Second-Generation
- Antipsychotic Agents
- Serotonin Antagonists
Cross-references
Synonyms
- Ritanserine
- Ritanserina
- NSC-758470
- R 55,667
- R-55667
- Tiserton
- Ritanserinum
- Ritanserinum [Latin]
- Ritanserine [French]
- Ritanserina [Spanish]
- UNII-145TFV465S
- C27H25F2N3OS
- 6-(2-(4-(bis(4-fluorophenyl)methylene)piperidin-1-yl)ethyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one
- MLS000069360
- CHEMBL267777
- 6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
- N,N-dialkyl-dipeptidylamines
- R 55667
- NSC 758470
- DTXCID7022594
- CHEBI:64195
- RefChem:389267
- R55667
- MFCD00069341
- NCGC00015877-06
- SMR000058511
- CAS-87051-43-2
- SR-01000000024
- Ritanserin [USAN:INN:BAN]
- Ritanserin, powder
- Tiserton (TN)
- Spectrum_001830
- RITANSERIN [MI]
- Lopac-R-103
- RITANSERIN [INN]
- Opera_ID_1609
- Ritanserin (USAN/INN)
- Spectrum2_001560
Look up RITANSERIN in the interactive SynDRA portal →